ArticleFrontiers in veterinary science2026
Effects of dietary N-carbamylglutamate supplementation on growth performance, meat quality, and cecal microbiota in Huoyan geese.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated dietary N-carbamylglutamate (NCG) effects on growth performance, body size indices, meat quality, and intestinal morphology in Huoyan geese, aiming to identify the optimal supplemental dose. Only the control and 0.06% NCG groups underwent 16S rRNA sequencing to explore associations between cecal microbiota and meat quality. A total of 240 one-day-old female geese were randomly assigned to four groups, each with six replicates of 10 birds, and fed a basal diet (control group) vs. basal diets supplemented with 0.06, 0.12, and 0.18% NCG groups, respectively, over a 30-week period. Growth performance, body size measurements, and meat quality traits were assessed, and cecal microbial communities were analyzed via 16S rRNA sequencing. From week 6 onward, the 0.06% NCG group exhibited the highest body weight through week 30, with superior average daily gain during the critical 4-8 week growth phase while maintaining normal average daily feed intake. From week 6 through week 30, the 0.06% NCG group had the highest body weight, with superior ADG during weeks 4-8 and while maintaining normal ADFI. Compared with controls, 0.06% NCG significantly increased body oblique length, shank length, and shank circumference (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.